These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11983802)

  • 21. Ice: cool drug or real problem?
    Fulde GW; Wodak A
    Med J Aust; 2007 Apr; 186(7):334-5. PubMed ID: 17407427
    [No Abstract]   [Full Text] [Related]  

  • 22. A systematic review of risk factors for methamphetamine-associated psychosis.
    Arunogiri S; Foulds JA; McKetin R; Lubman DI
    Aust N Z J Psychiatry; 2018 Jun; 52(6):514-529. PubMed ID: 29338289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional polymorphism of the NQO2 gene is associated with methamphetamine psychosis.
    Ohgake S; Hashimoto K; Shimizu E; Koizumi H; Okamura N; Koike K; Matsuzawa D; Sekine Y; Inada T; Ozaki N; Iwata N; Harano M; Komiyama T; Yamada M; Sora I; Ujike H; Shirayama Y; Iyo M
    Addict Biol; 2005 Jun; 10(2):145-8. PubMed ID: 16191666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methamphetamine psychosis: epidemiology and management.
    Glasner-Edwards S; Mooney LJ
    CNS Drugs; 2014 Dec; 28(12):1115-26. PubMed ID: 25373627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methamphetamine: Effects on the brain, gut and immune system.
    Prakash MD; Tangalakis K; Antonipillai J; Stojanovska L; Nurgali K; Apostolopoulos V
    Pharmacol Res; 2017 Jun; 120():60-67. PubMed ID: 28302577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methamphetamine psychosis in which tardive dystonia was successfully treated with clonazepam.
    Yamamoto N; Oda T; Inada T
    Psychiatry Clin Neurosci; 2007 Dec; 61(6):691-4. PubMed ID: 18081635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Letter to the Editor-Is Chronic Methamphetamine-Induced Psychosis A Mental Disease for the Purposes of Insanity?
    Reisner AD; Piel JL
    J Forensic Sci; 2020 Jul; 65(4):1382-1383. PubMed ID: 32396213
    [No Abstract]   [Full Text] [Related]  

  • 28. The risk and associated factors of methamphetamine psychosis in methamphetamine-dependent patients in Malaysia.
    Sulaiman AH; Said MA; Habil MH; Rashid R; Siddiq A; Guan NC; Midin M; Nik Jaafar NR; Sidi H; Das S
    Compr Psychiatry; 2014 Jan; 55 Suppl 1():S89-94. PubMed ID: 23433219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Infantile psychosis secondary to methylphenidate].
    Fernández-Fernández MA; Rufo-Campos M; Mateos-Checa R; Muñoz-Cabello B; Madruga-Garrido M; Blanco-Martínez B
    Rev Neurol; 2011 Apr; 52(7):446-7. PubMed ID: 21425116
    [No Abstract]   [Full Text] [Related]  

  • 30. Structural, functional, and neurochemical neuroimaging of methamphetamine-associated psychosis: A systematic review.
    Chen C; Hsu FC; Li CW; Huang MC
    Psychiatry Res Neuroimaging; 2019 Oct; 292():23-31. PubMed ID: 31476712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of methamphetamine assist packs: As-needed antipsychotics for self-management of methamphetamine-associated psychiatric toxicity.
    Coffin PO; Chang YG; McDaniel M; Leary M; Pating D; McMahan VM; Goldman ML
    Int J Drug Policy; 2024 Jul; 129():104480. PubMed ID: 38861841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exacerbation of psychosis by phenylpropanolamine.
    Goodhue A; Bartel RL; Smith NB
    Am J Psychiatry; 2000 Jun; 157(6):1021-2. PubMed ID: 10831490
    [No Abstract]   [Full Text] [Related]  

  • 33. Quantitative drug levels in stimulant psychosis: relationship to symptom severity, catecholamines and hyperkinesia.
    Batki SL; Harris DS
    Am J Addict; 2004; 13(5):461-70. PubMed ID: 15764424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Minocycline as a therapeutic drug for methamphetamine use disorders].
    Hashimoto K
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Feb; 28(1):19-22. PubMed ID: 18411705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stimulant psychosis: systematic review.
    Curran C; Byrappa N; McBride A
    Br J Psychiatry; 2004 Sep; 185():196-204. PubMed ID: 15339823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lower folate levels in methamphetamine-induced psychosis: A cross-sectional study.
    Hadizadeh H; Salehi M; Bozorgnia AR; Ahmadkhaniha HR
    Drug Alcohol Depend; 2020 Feb; 207():107682. PubMed ID: 31841749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute exacerbation of methamphetamine psychosis and lasting dopaminergic supersensitivity--a clinical survey.
    Sato M
    Psychopharmacol Bull; 1986; 22(3):751-6. PubMed ID: 3797580
    [No Abstract]   [Full Text] [Related]  

  • 38. Caffeine-induced psychiatric manifestations: a review.
    Wang HR; Woo YS; Bahk WM
    Int Clin Psychopharmacol; 2015 Jul; 30(4):179-82. PubMed ID: 25856116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. No significant association between SIRT1 gene and methamphetamine-induced psychosis in the Japanese population.
    Kishi T; Fukuo Y; Okochi T; Kitajima T; Ujike H; Inada T; Yamada M; Uchimura N; Sora I; Iyo M; Ozaki N; Correll CU; Iwata N
    Hum Psychopharmacol; 2011 Oct; 26(7):445-50. PubMed ID: 21882241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Involvement of prefrontal serotonergic neurons in methamphetamine-induced behavioral sensitization].
    Ago Y; Nakamura S; Arikawa S; Yata M; Matsuda T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Apr; 28(2):85-91. PubMed ID: 18516987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.